BBHC
IRMD icon

Brown Brothers Harriman & Co’s iRadimed IRMD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2K Hold
117
– – ﹤0.01% 1404
2026
Q1 		$11.3K Buy
117
+63
+117% +$6.3K ﹤0.01% 1333
2025
Q4 		$5.25K Hold
54
– – ﹤0.01% 1494
2025
Q3 		$3.84K Buy
+54
New +$3.6K ﹤0.01% 1473

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Brothers Harriman & Co's IRMD Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its iRadimed (IRMD) position steady in Q2 2026 at 117 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Brown Brothers Harriman & Co first reported a position in IRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.3K in Q1 2026. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Brown Brothers Harriman & Co held 117 shares of iRadimed worth $11.2K as of Q2 2026.
  • Brown Brothers Harriman & Co left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1404 holding.
  • Brown Brothers Harriman & Co first reported a position in iRadimed in Q3 2025 and has held it in 4 quarters since.
  • Brown Brothers Harriman & Co's iRadimed position peaked at $11.3K in Q1 2026.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.